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Abstract: An on-line intelligent advisory system (IAS) for the management of septic patients emerging 
from cardiopulmonary bypass (CPB) has been developed and evaluated on a comprehensive physiological 
model which incorporates sepsis-induced capillary leak and the hemodynamic response to Intensive Care 
Unit (ICU)-like therapeutic interventions. The IAS is composed of the expert’s decision-making model 
which performs diagnosis and designates the appropriate therapeutic actions based on the patient’s 
hemodynamic status and a multi-inputs multi-outputs self-organising fuzzy logic controller (SOFLC) for 
adjusting the infusion rates of the selected drugs to maintain the hemodynamics variables at the specified 
target values. Simulated patient scenarios reproducing post-CPB hemodynamic abnormalities were 
developed with the expert anesthetist to test the IAS ability to advice for the appropriate therapeutic 
interventions whilst controlling individual drugs infusion rates to maintain the hemodynamic parameters at 
the prescribed targets values. 
 
1. INTRODUCTION 
Septic shock is the most severe pathophysiological condition 
on the continuum of the body response to infection. Patients 
with sepsis show evidence of infection and clinical 
manifestations of inflammation. Severe sepsis is the 
development of hypoperfusion with organ dysfunction in a 
septic patient, and septic shock is hypoperfusion and 
persistent hypotension in patients with sepsis. Most studies 
show that mortality rates lie between 40% and 60% for most 
types of infections leading to septic shock (Dellinger, 2003). 
Major surgery carries a risk of exogenous infection through 
exposed surfaces and intravenous lines, but studies have 
shown that 90% of the organisms implicated in septic shock 
come from the body’s internal flora. Alterations in peripheral 
vascular tone and cardiac function contribute to the 
cardiovascular manifestations of septic shock (Bridges and 
Dukes, 2005; Parillo, 1989). Heart rate and cardiac output 
commonly remain normal or increase. Systemic vascular 
resistance (SVR) is low because arteriolar tone is decreased. 
Despite the increase in cardiac output (CO), tissue 
hypoperfusion is characterised by a raised blood lactate 
concentration, with oxygen extraction at less than maximum 
(Astiz and Rackow, 1998). Experimental studies show a loss 
of capillary cross section, and unusual microvascular effects 
such as the shunting of blood past organs (Groscott and 
Mythen, 2001). Hypovolemia is a major factor that 
contributes to the initial hemodynamic instability in septic 
shock. Patients have characteristically a low cardiac filling 
pressure and a low cardiac output in the early stages of shock. 
Their cardiac output only increases after fluid resuscitation. 
Hypovolemia is caused by a decreased venous tone, which 
increases the capacity of the veins. Much of the circulating 
volume is also lost through a capillary leak, as sepsis 
increases the microvascular permeability. Fluid is lost in the 
“third space”, and reabsorbed if and when the underlying 
infection is treated. Coronary perfusion and myocardial 
oxygen metabolism remain normal during septic shock. 
However, some myocardial dysfunction is seen in most 
patients with septic shock, especially in post heart surgery 
patient population. 
Clinicians must continuously monitor the condition of the 
patient using a variety of invasive and non-invasive measures 
at the same time as devising and executing an appropriate 
treatment plan. After identifying and reversing the cause of 
infection with antibiotics, the main method of managing sep-
sis/septic shock is with intravenous fluid and drug infusions. 
The clinician typically has a large number of drugs to choose 
from to treat each manifestation of sepsis. The infusion rates 
are set in order to maintain patient stability and drive meas-
ured parameters towards clinical endpoints. The skills and 
thought processes needed for this have been likened as much 
to an art than a science. This takes place against the hectic 
backdrop of an ICU during open-heart surgery where goals 
may change at the surgeons request or in response to the pa-
tient’s condition. 
A computerised decision support/advisory system can prove 
particularly useful in this challenging control environment. 
In this research study an intelligent advisory system (IAS) 
integrating expert knowledge and self-organising fuzzy logic 
control theory is developed for automating the decision-
making strategies in septic patients emerging from cardiac 
surgery and treated with cardiopulmonary bypass (CPB). The 
 IAS is comprehensively tested on a physiological model 
describing the human cardiovascular mechanics and 
fluid/proteins exchange in the capillaries. The physiological 
model hence developed can reasonably reproduce the major 
hemodynamic abnormalities observed in cardiac septic 
patients and successfully predicts the response to different 
therapeutic interventions such us fluid, inotropic drugs, 
vasoconstrictor and vasodilators.  
The rest of the paper is organized as follows. Section 2 
focuses on the description of the physiological model. 
Section 3 deals specifically with the description and 
implementation aspects of the IAS. Section 4 presents a 
simulation study to evaluate the SOFLC-based hemodynamic 
controller. The evaluation of the IAS under different model 
scenarios replicating common conditions observed in post-
CPB septic patients is presented in section 5. Finally, 
conclusions relating to this research contribution are 
summarised in Section 6 of the paper. 
2. PHYSIOLOGICAL MODELING OF THE CARDIAC 
FUNCTION IN SEPTIC PATIENTS 
The objective here was to develop a physiological model that 
is able to reproduce the key hemodynamic variables of the 
cardiovascular function during and after CPB. The physio-
logical model depicted in Fig. 1 combines ideas and equa-
tions from two previous models of the cardiovascular hemo-
dynamics (Randall, 1986; Mason, 1989) and fluid exchange 
in the microcirculation (Xie, 1995). 
 
Fig. 1. Schematic diagram of the physiological model. 
Subscript ‘p’ denotes pulmonary, ‘s’ systemic, ‘a’ arterial and 
‘v’ venous (Randall, 1986; Mason, 1989; Xie, 1995) 
 
The flow through the left and right heart, i.e. the cardiac 
output, is described by the following empirically derived 
equations: 
 
ܥ ௟ܱ ൌ ܭ௟ ڄ ܪܴ ڄ ൫ ௣ܲ௩ െ ܿ ڄ ௦ܲ௔ ൅ 1൯                                         ሺ1ሻ    
ܥ ௥ܱ ൌ ܭ௥ ڄ ܪܴ ڄ ൫ ௦ܲ௩ െ ܿ ڄ ௣ܲ௔ ൅ 1൯                                        ሺ2ሻ     
 
Where Kl and Kr are the contractilities of the left and right 
ventricle, P is the pressure and HR is the heart rate. 
Subscripts p and s denote pulmonary and systemic, v and a 
denote veins and arteries. The compliance and resistance 
parameters were taken from (Xie, 1995; Gyenge et al., 1999). 
The baroreflex effect on the mean arterial pressure (MAP) to 
the heart rate (HR) and systemic vascular resistance (SVR) is 
represented by a piecewise linear relationship with transport 
delay. Drug effects were incorporated in a similar way. A 
piecewise linear relationship with transport delay was 
assumed to exist between drug infusion and its effect on SVR 
and ventricles’ contractilities (Kl, and Kr). The model was 
able to simulate the effects of vasodilators, vasopressors and 
inotropes. New drugs can be trivially added to this model by 
defining the infusion rate/effect relationship. In addition, 
fluid can be added to the circulation to simulate fluid 
resuscitation in response to hypovolemia and/or low blood 
pressure. A constant urine output was also included in the 
model.  
The Cardiovascular System (CVS) model is extended with an 
additional compartment describing the transport and 
distribution of fluid and plasma proteins between the 
circulation and the interstitial space (Xie, 1995; Gyenge et 
al., 1999). In the microcirculation, fluid and protein balance 
is maintained by hydrostatic and oncotic pressures existing 
on either sides of the capillary barrier according to Starling’s 
equation which described the rate of fluid filtration from the 
circulation to the interstitial space (Gyenge et al., 1999; 
Klabunde, 2004).  
 
ܬ௜ ൌ ܭ௙ሾሺ ௖ܲ െ ௜ܲሻ െ ߪሺߎ௖ െ ߎ௜ሻሿ                                              ሺ3ሻ  
 
Where Ji represents the net fluid movement between the 
compartments, ܭ௙ is the fluid filtration coefficient, ௖ܲ and ௜ܲ 
represent the capillary and interstitial hydrostatic pressures 
respectively, ߎ௖ and ߎ௜ represent the capillary and interstitial 
oncotic pressures respectively, σ denotes the reflection 
coefficient, a measure of the permeability of the capillaries to 
the proteins responsible for generating the oncotic pressure. 
Different pathophysiological conditions can be simulated by 
changing the model parameters. Reducing the reflection coef-
ficient σ by 50% increases the permeability of the capillaries, 
causing a capillary leak of over 500ml. This, in turn, causes a 
reduction in MAP and CO, mimicking the initial effects of 
sepsis induced capillary leak. However, in many real patients 
the reflexes will raise the HR and heart contractility, hence 
maintaining CO.  
Increasing the SVR will cause an increase in MAP. However, 
the increased afterload will reduce the CO. SVR may change 
due to drugs or reflex responses. The onset of severe sepsis is 
accompanied by an impairment of the autonomous nervous 
system leading to a compromised baroreflex function with a 
deregulation in the sympathetic and parasympathetic 
activities. Therefore, to better illustrate the interaction 
between drugs and the physiological model, the baroreflex 
function has been disabled in this simulation study. 
The model parameters have been tuned (optimized) using real 
clinical data (Hamada et al., 2004). 
3. DESIGN METHODOLOGY OF THE IAS FOR 
CARDIAC SEPTIC PATIENTS 
The overall structure of the IAS depicted in Fig. 2 integrates 
the fuzzy decision rule-base which performs diagnosis based 
on the hemodynamic parameters and selects the appropriate 
 therapy and a set of SOFLC to adjust the infusion rates of 
drugs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: Schematic diagram of the IAS with the patient’s 
model 
3.1  Decision Rule Base 
The authors have elaborated, in collaboration with an expert 
anesthetist (Ross et al., 2006), a conceptual model of the 
customary clinical decision pathway that a senior anesthetist 
with substantial experience uses to support post-CPB 
patients. The model refers to five components of the CVS 
mainly the systolic blood pressure (SBP), central venous 
pressure (CVP), systemic vascular resistance (SVR), cardiac 
output (CO) and heart rate (HR). The decision levels 
associated with these components are prioritized as shown in 
Fig. 3.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Synopsis of the decision-making model 
However, as it is a dynamic environment, and treatments may 
have effects on several components, it is necessary to 
continuously revisit those previously treated. 
The Decision Rule Base implementing the decision model of 
Fig. 3 were encoded as a set of fuzzy linguistic rules as it 
seemed the most natural translation between the expert’s 
knowledge, the inputs and a crisp decision. Defining 
acceptable bounds for each fuzzy set presented some 
difficulty as these may change under different circumstances. 
Additionally, values such as the CVP and the HR may not 
have ideal values as such; they are relative to the pre-surgery 
values for each patient. Since information like this cannot be 
encoded into a one size fits all rule-base, it is important that 
these can be modified by the user in any implementation. An 
example of fuzzy partition is shown in Fig. 4 for the MAP. 
 
Fig. 4. Membership functions definition for the MAP 
3.2  Design of the Multiple-Drug SOFLC Controller 
Self-organising fuzzy logic control (SOFLC) works on the 
principle of continuous on-line performance evaluation, and 
if necessary, rule modification of an existing fuzzy logic 
controller, as proposed by (Procyk and Mamdani, 1979). 
Usually, the error and the change in error are taken as inputs, 
and the output is the required change in the control action - PI 
type controller. The basic configuration of a SOFLC is shown 
in Fig. 5. 
 
 
 
 
 
 
 
Fig. 5. Basic configuration of SOFLC 
Where e and ሶ݁ denote the error (difference between the 
hemodynamic variable and its target value) and error change 
respectively and u in the controller output representing the 
infusion rate of the drug to be administered under these 
conditions. The input and output gains were adjusted through 
trial and error. The performance index describing the desired 
response is usually in the form of rules which indicate the 
correction needed to the control output and hence the fuzzy 
rule-base. This correction is applied to the past control output 
most responsible for the current undesirable state, hence 
some knowledge of plant delays is necessary. In equation 
form, the adjustment rule is as follows: 
 
ܨሺ݅, ݆ሻ௡ିௗ ൌ ܨሺ݅, ݆ሻ௡ିௗ ൅ ܲܫሺ݅, ݆ሻ௡ିௗ                             (4) 
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 Where F is the current rule base, i and j are the indices which 
correspond to the current error and change of error, PI is the 
performance index, n is the current sample time and d is the 
delay. 
A third-order polynomial filter with a window of 20 samples 
was used to improve the performance of the SOFLC under 
noisy conditions. Polynomial filtering uses a least-squares 
fitting of a polynomial function to the noisy signal over a 
fixed window. The general form of this estimated function is: 
݌ሺݔሻ ൌ ෍ܿ௞
௠
௜ୀଵ
߶௞ሺݔሻ                                                                    ሺ5ሻ 
Where φ(x) is the kth order polynomial function, the factors c1 
to cm can be found by solving the following equation: 
∂ ܧ
∂  ௝ܿ ൌ ෍2 ൥෍ܿ௜
௠
௜ୀଵ
߶௜൫ݔሺ݇ሻ൯ െ ݕሺ݇ሻ൩
௡
௞ୀଵ
߶௝൫ݔሺ݇ሻ൯ ൌ 0          ሺ6ሻ 
Where ܧ ൌ ∑ ൣ∑ ܿ௜߮௜൫ݔሺ݇ሻ൯ െ ݕሺ݇ሻ௠௜ୀଵ ൧
ଶ௡
௞ୀଵ  
A window of n samples of noisy data ሺݕሺ݇ሻ, ݇ ൌ ݐ െ ݊ ൅
1, ݐ െ ݊ ൅ 2,ڮ , ݐሻ is used to calculate the current smoothed 
data point ݕොሺݐሻ ൌ ∑ ܿ௜߶௜൫ݔሺݐሻ൯௠௜ୀଵ  using the previously 
calculated factors. The smoothed signal ݕොሺݐሻ and its 
derivative ݕොሺݐሻ െ ݕොሺݐ െ 1ሻ are used in the control scheme. 
Vasoactive and inotropic drugs have direct effects on their 
sites of action; however there may also be indirect effects and 
secondary effects on other parameters. For instance, a pure 
vasoconstrictor will not only raise the systemic blood 
pressure, it will affect the pressure immediately before and 
after the heart and change the cardiac output. In multivariable 
control such interaction can have two undesirable effects: 
● Cross-coupling between main loops may lead to 
large output fluctuations especially in the mid-
frequency range; 
● It may make controller tuning more difficult. 
Relative gain array (RGA) (Bristol, 1966) provides a measure 
of control interaction and a method of reducing its effects. 
The RGA for an n-input n-output system can be defined as 
follows: 
߉ ൌ ൦
ߣଵଵ ߣଵଶ ڮ ߣଵ୬
ߣଶଵ ߣଶ୬
ڭ ڭ
ߣ௡ଵ ߣ௡ଶ ڮ ߣ௡௡
൪                                                  (7) 
 
Where 
ߣ௜௝ ൌ
Open loop gain betweenݕ௜&ݑ௝
Closed loop gain betweenݕ௜&ݑ௝
                                   ሺ8ሻ 
 
For a two-input/two-output system, λ11 can be defined as 
follows 
ߣଵଵ ൌ
1
1 െ ܭଵଶ ڄ ܭଶଵܭଵଵ ڄ ܭଶଶ
                                                                    ሺ9ሻ 
 Where 
ܭଵଵ ൌ
߂ݕଵ
߂ݑଵ
 with respect to ݑଶ ܭଵଶ ൌ
߂ݕଵ
߂ݑଶ
 with respect to ݑଶ 
ܭଶଵ ൌ
߂ݕଶ
߂ݑଵ
 with respect to ݑଶܭଵଶ ൌ
߂ݕଶ
߂ݑଶ
 with respect to ݑଶ 
 
The other terms of Λ can be easily calculated as all rows and 
column sum to 1. The modified inputs ˉݑ can then be defined 
as ˉݑ ൌ ߉ݑ. RGA provides a powerful way of measuring and 
compensating for loop interactions. However, on its own it 
does have significant weaknesses. This method will not pro-
vide perfect decoupling as it assumes a linearised model 
around some operating point. Steady state interaction meas-
ures may not always predict performance under dynamic con-
trol (McAvoy, 1981). In the non-linear case, inputs may af-
fect each other by differing amounts in different ranges, or 
not at all.  However, it significantly reduces the instability 
caused by interactions in this control scheme. 
4. EVALUATION OF THE MULTIPLE-DRUG SOFLC 
HEMODYNAMIC CONTROLLER 
The Multiple-Drug SOFLC (MSOFLC) with The 
Multivariable SOFLC (MSOFLC) with RGA decoupling and 
noise filter has been extensively tested on the physiological 
model in a simple closed-loop control scheme. The MAP and 
CO were simultaneously controlled using noradrenaline and 
dopamine. A noise signal with a power equivalent to 2% of 
the signal strength was added to the model outputs and a 
third-order polynomial filter was implemented, using a 
window of 20 data-points to perform adequate smoothing. 
The results of Fig. 6 show the simultaneous control of MAP 
and CO to their respective target values without and with the 
designed smoothing filter. 
 
 
Fig. 6. MSOFCL control with RGA decoupling of MAP and 
CO with noradrenaline and dopamine respectively: Without 
smoothing filter (top panel) and with smoothing filter 
(bottom panel)  
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 The SOFLC was able to maintain control of MAP and CO 
within 10% of the target values. Polynomial filtering provides 
effective noise attenuation, however this adds a marked 
computational burden as least squares fitting must take place 
at each time step. The interactions effects among the 
controlled hemodynamic parameters have been successfully 
reduced using RGA decoupling, although this will not 
provide the same benefit at all ranges. The initial response 
time of the SOFLC can be improved using expert knowledge 
as it takes time for the controller to generate rules and for the 
control action to ramp up from zero. 
 
5. EVALUATION OF THE INTELLIGENT ADVISORY 
SYSTEM VIA THE PATIENT PHYSIOLOGICAL MODEL 
Patients with severe sepsis develop an increased 
microvascular permeability of the capillary barrier and 
interstitial edema. To simulate the capillary leak condition, 
the reflection coefficient σ of the model was reduced by 30% 
causing a net shift of 500 ml of fluid from the circulation to 
the interstitium. In addition the SVR was reduced and the 
contractility increased. As shown in Fig. 7, this caused the 
MAP and CVP to drop to 70 mmHg and 5.2 mmHg 
respectively. This in turn triggered the “low MAP” rule which 
started the infusion of a vasoconstrictor hence driving the 
MAP to 100 mmHg. This takes quite a long time because the 
SOFLC is starting from an empty rule-base. The CVP is still 
low, which triggers the "low CVP" rule hence initiating the 
infusion of a 250 ml bolus of fluid at 12.5ml/min. Fluid 
administration caused, on the other hand MAP to increase 
over 120, subsequently firing the "high MAP" rule. However, 
the way the expert’s decision model is implemented here the 
“High MAP” will not start vasodilator therapy unless 
hypertension still persists after the infusion rate of the 
vasoconstrictor which is being administrated has been 
progressively reduced and stopped. As the amount of 
vasoconstrictor was reduced, the MAP decreased to 100 
mmHg. Note that this response is faster as the SOFLC rule-
base has been filled from the first response.  
 
Fig.7. Simulation of a patient with capillary leak, 
vasodilation and increased contractility 
In the scenario of Fig. 8, the contractility (Kl and Kr) was 
reduced, causing a drop in cardiac output to 3.6 l/min. As the 
model hadn't reached steady state at the beginning of the 
simulation, the pressure changes cause fluid shifts which are 
much slower than the other dynamics. This triggered the "low 
CO" rule, and the CO was driven towards 5 l/min with 
dopamine. 
 
Fig. 8. Simulation of a patient with low CO 
To simulate hypertension, SVR was increased from its 
baseline value. As shown in Fig. 9, this has caused an 
increase in the MAP to 119 mmHg. The MAP setpoint was 
95 mmHg when the advisory system was started. This 
triggered the "high MAP" rule and the MAP is driven 
towards 95 mmHg with a vasodilator. At 150 minutes, the 
MAP setpoint is reduced to 80 mmHg. This triggers the "high 
MAP" rule and the MAP is driven towards 80 mmHg with a 
vasodilator. 
 
Fig. 9. Simulation of a patient with hypertension 
In Fig. 10, the baseline parameters for Rs, Kl, Kr and σ have 
been changed from their nominal values to those simulating a 
septic patient. Fig. 10 starts when the MAP has dropped 
below 80 mmHg, and the first rule triggered was "low MAP" 
rule. The MAP is driven towards 100 mmHg with a 
vasoconstrictor. The CVP is below 4 mmHg therefore firing 
the "low CVP" rule and a 250 ml bolus of fluid at 12.5ml/min 
is given. The CVP is still low after this, triggering a second 
bolus. The MAP has risen to over 110 mmHg by this stage 
triggering the "high MAP" rule. This drives the MAP back to 
100 mmHg by reducing the vasoconstrictor level. There is a 
third "low CVP" rule fluid bolus at 180 min, followed by a 
"low CO" state. The CO is driven to 5 l/min with dopamine. 
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Fig. 10. Simulation of a septic patient 
Finally, in Fig. 11, the contractility (Kl, Kr) is reduced as well 
as the sensitivity of the model to dopamine. The model enters 
the "low CO" state and the advisory system reaches the 
maximum infusion of dopamine, then switches to the second 
drug choice for the "low CO" state. 
 
Fig. 11. Simulation of a patient with reduced contractility and 
drug sensitivity 
6. CONCLUSIONS 
Post-cardiopulmonary bypass (CPB) patients are susceptible 
to major hemodynamic instabilities as a result of the 
transient, multiple physiological derangements associated 
with CPB and the surgery itself. Sepsis/septic shock remain 
of the most frequently diagnosed conditions encountered in 
these critically ill patients. Supportive treatment of septic 
shock patients, parallel to reversing the cause of infection, 
includes fluid resuscitation and vasoactive medication to 
restore normal blood pressure and improve the circulatory 
performance. This control environment is well-defined and 
hierarchical which makes it suitable for a computerized 
implementation. The authors have developed a clinical 
advisory system for the management of post-cardiac septic 
patients. The hierarchical advisory system operating in 
closed-loop has been tested on a physiological model of the 
cardiovascular hemodynamics under a wide range of 
simulated pathological conditions characterizing post-CPB 
septic patients. In all the simulated patients scenarios the 
advisory system was able to trigger the adequate decision 
rule, initiate the right therapeutic action and control the 
hemodynamic parameters to the prescribed target values. 
The proposed advisory has been designed with a sufficient 
degree of flexibility to allow future extensions to be made to 
enhance its functionality and performance. The system can be 
easily configured to accommodate a larger number of 
monitored variables and extended to accommodate 
alternative decision hierarchies to adhere with the clinician’s 
workflow and/or preference in the management of post-CPB 
patients.  
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